Loading insider details...
Beta
Latest Form 4 (Jul 10, 2026): Grant/Award of 6,500 MCRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 6,500 | n/a |
| Jul 2, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 7,508 | n/a |
| Jun 5, 2026 | Sana Biotechnology, Inc. (SANA) | Grant/Award | 90,000 | n/a |
| Aug 6, 2025 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 10,000 | n/a |
| Jun 9, 2025 | Sana Biotechnology, Inc. (SANA) | Grant/Award | 115,000 | n/a |
| Oct 4, 2024 | Omega Therapeutics, Inc. (OMGA) | Grant/Award | 50,000 | n/a |
| Jun 12, 2023 | Evelo Biosciences, Inc. (EVLO) | Grant/Award | 30,000 | n/a |
| Apr 18, 2023 | Evelo Biosciences, Inc. (EVLO) | Grant/Award | 40,000 | n/a |